Rights and permissions
About this article
Cite this article
All patients with ALS should be entitled to riluzole therapy. Pharmacoecon. Outcomes News 138, 7 (1997). https://doi.org/10.1007/BF03285560
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03285560